TMC-647055
TMC-647055[edit | edit source]
TMC-647055 is a chemical compound that has been studied for its potential use in the treatment of hepatitis C. It is classified as a non-nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase, which is an enzyme critical for the replication of the virus.
Mechanism of Action[edit | edit source]
TMC-647055 functions by binding to the NS5B polymerase of the hepatitis C virus. This binding inhibits the activity of the polymerase, thereby preventing the replication of the viral RNA. The NS5B polymerase is an RNA-dependent RNA polymerase that is essential for the replication of the HCV genome. By inhibiting this enzyme, TMC-647055 disrupts the life cycle of the virus, reducing viral load in infected individuals.
Development and Clinical Trials[edit | edit source]
TMC-647055 has been evaluated in various clinical trials to assess its efficacy and safety in patients with hepatitis C. These trials have explored its use both as a monotherapy and in combination with other antiviral agents. The compound has shown promise in reducing viral load and improving liver function in patients with chronic hepatitis C infection.
Pharmacokinetics[edit | edit source]
The pharmacokinetics of TMC-647055 have been studied to understand its absorption, distribution, metabolism, and excretion in the human body. The compound is typically administered orally, and its bioavailability can be affected by factors such as food intake and liver function. TMC-647055 is metabolized primarily in the liver and excreted through the kidneys.
Side Effects[edit | edit source]
Like many antiviral medications, TMC-647055 can cause side effects in some patients. Common side effects include nausea, fatigue, and headache. More serious side effects are rare but can include liver toxicity and allergic reactions. Patients receiving TMC-647055 are typically monitored for these adverse effects during treatment.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
